September 2017

NCI Standard Funding Opportunity Announcements

Current and Recent Program Announcements  |  Current and Recent Requests for Applications
Current and Recent NCI and Trans-NIH Initiatives | Requests for Proposals  |  Standard Due Dates


Open All Ranks Non-federal Clinical Trials

The Gateway for Cancer Research
Research Grants

 
Gateway focuses on transformational science via effective clinical trials - when basic science translates into human testing and clinical practice.
Due Dates: Rolling requests for funding conducted in two stages: a Letter of Intent (LOI) and if invited, a full application. Applicants must submit via Gateway's Grant Management System  
Amount & Project Period: Funding is variable and duration is 1 to 3 years
Eligibility: All Ranks
Contact: Gateway Contacts are: Jerian Dixon-Evans, Research Grants Specialist  Jerian.Dixon-Evans@gatewaycr.org (847) 342-7361 and Domarina Oshana, Ph.D., Director of Research and Grants Domarina.Oshana@gatewaycr.org (847) 342-7443
Link: Grant Application Process


Ongoing All Ranks Federal See BAA

Army Research Office Broad Agency Announcement (BAA)
Basic and Applied Scientific Research
W911NF-17-S-0002 01
April 2017 - 31 March 2022

The purpose of this BAA is to solicit research proposals in the engineering, physical, life, and information sciences for submission to the Army Research Office (ARO) for consideration for possible funding. Whitepapers and proposals will be evaluated only if they are for fundamental scientific study and experimentation directed toward advancing the scientific state of the art or increasing basic knowledge and understanding. 
Due Dates: Open until Mar. 31, 2022
Proposers are to submit white papers prior to submission of a complete proposal. Based on assessment of white papers, feedback will be provided to encourage or discourage submission of full proposals.
Amount & Project Period: No specific dollars have been reserved - 3 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
Link: W911NF-17-S-0002


Ongoing Postdocs/Junior Faculty Non-federal Pediatric Brain Tumors

A Kids' Brain Tumor Cure Foundation (aka The PLGA Foundation)
Research Grants

Proposals related to basic and translational projects that can advance understanding of the underlying biology of the development and treatment of pediatric low grade glioma brain tumor (PLGA) tumors will be considered.
Due Dates: Letters of Intent are accepted on an ongoing basis, and are reviewed by an expert panel. Based on this feedback, selected applicants will be invited to submit a full proposal
Amount & Project Period: Funding is based on size, complexity, and potential impact of project, and can be awarded over a one-, two-, or three-year period.
Eligibility: Investigators in the early years of their careers are encouraged to apply.  
Contact: Office of Sponsored Research (x6804)
Link: Apply for an AKBTC Sponsored Grant
R01 NIH


Updated Information
To Be Announced All Ranks Federal See Opportunities Below

Cancer Moonshot

Implementation Teams have identified nine upcoming opportunities addressing the goals of the Cancer Moonshot.  These funding opportunities that have been approved by the NCI Board of Scientific Advisors will be published over the coming months with funding anticipated in fiscal year 2018.  The nine opportunities are listed below and all investigators are encouraged to sign up to receive automatic updates as more information becomes available.
Contact: Office of Sponsored Research (x6804)
Links: 1.     Immuno-Oncology Translational Network (IOTN)
2.     Pediatric Immunotherapy Discovery and Development Network (PI-DDN)
3.    Mechanisms of Cancer Drug Resistance and Sensitivity Network Coordinating Center
4.     Collaborative Research Network for Fusion Oncoproteins in Childhood Cancers
5.     Common Terminology Criteria for Adverse Events (CTCAE) and Patient Reported Outcomes-CTCAE (PRO-CTCAE)
6.     Improving Management of Symptoms Across Cancer Treatments (IMPACT)
7.     Approaches to Identify and Care for Individuals with Inherited Cancer Syndromes
8.     Accelerating Colorectal Cancer Screening and Follow-Up Through Implementation Science (ACCSIS)
9.    Human Tumor Atlas (HTA) Network  


August 20 (LOI) All Faculty Non-Federal Clinical Cancer Research

Rising Tide Foundation
Clinical Cancer Research - Cycle 3

The purpose of the program is to advance studies that deliver results for cancer patients and empower individuals to develop their skills to make a difference for themselves and the greater community.  RTF supports truly innovative, unique, patient-centered research that has the potential to positively impact the lives of cancer patients in near future. Early stages clinical studies and translational research that can demonstrate the potential for quick and meaningful impact are funded. Basic research or phase III/IV trials are not supported.
Due Dates: Aug. 20 (Letter of Intent) - If the proposed project meets Rising Tide's funding criteria, an invitation will be extended for submission of a full grant application for further consideration.
Amount & Project Period: The amount of each award is based on the availability of funds. The duration of the award is up to five years or less.
Eligibility: All Faculty
Contact: Office of Sponsored Research - (x6804)
Link: How to apply Ι Program Guidelines


August 24
(Pre-Application)		 See Below Federal Prostate

Congressionally Directed Medical Research Programs
Prostate Cancer Research Program (PCRP)

Due Dates: Aug. 24 (Pre-application)
Use eBRAP (for pre-application submissions)
Applications Due:  Sept. 05 (OSR) Ι Sept. 07 (Sponsor) 
Contact: Office of Sponsored Research (x6804)
Primary Link: PCRP Program Announcements

Clinical Consortium Award
W81XWH-17-PCRP-CCA

This award mechanism provides the support to develop and enhance collaborations and resources necessary for a network of organizations to rapidly execute Phase II or Phase II-linked Phase I (Phase I/II) prostate cancer clinical trials, including investigations of high-impact, novel therapeutic agents or approaches for the management or treatment of prostate cancer. In accordance with PCRP goals, the conduct of Phase I/II trials incorporating investigations of biomarkers for risk assessment, early detection, prediction of aggressiveness, and/or progression of prostate cancer is particularly encouraged.  Support from this award is directed toward consortium infrastructure needs rather than direct support of the research itself.
Amount & Project Period: Coordinating Center: $3,600,000 (Direct Costs) - 3 years Clinical Research Sites:  $600,000 (Direct Costs) - 3 years Note:  Exercise of options for continued performance for each Clinical Research Site after the first year will be contingent upon meeting performance metrics outlined in program announcement.
Eligibility: PI must be independent investigator at or above Asst. Professor level (or equiv.)
PA Link:  W81XWH-17-PCRP-CCA
 

Prostate Cancer Pathology Resource Network Award
W81XWH-17-PCRP-PCPRNA

 This award mechanism is intended to provide infrastructure support for development and maintenance of a prostate cancer biorepository through a collaborative network across multiple institutions that will facilitate the collection, processing, annotation, storage, and distribution of high-quality human prostate cancer biospecimens.
Amount & Project Period: Combined total direct costs of Initiating PI and all Partnering PIs' awards will not exceed $3.6M direct costs. - 3 Years
Eligibility: PI must be independent investigator at or above Asst. Professor level (or equiv.) with access to appropriate facilities.
PA Link: W81XWH-17-PCRP-PCPRNA
U01 NIH
NCI is a participating Institute
August 31 (LOI) All Ranks Federal Multiscale Models of Cancer Processes

Predictive Multiscale Models for Biomedical, Biological, Behavioral, Environmental and Clinical Research

The goal of this interagency funding opportunity announcement (FOA) is to support the development of multiscale models to accelerate biological, biomedical, behavioral, environmental and clinical research. NCI is interested in supporting development of predictive multiscale models of cancer processes. These models may be designed to elucidate basic mechanisms underlying cancer initiation and progression and/or to address important translational, clinical or epidemiological questions related to cancer risk, prevention, diagnosis and treatment.
Due Dates: Letter of Intent requested 30 days prior to due date
Sept. 27 (OSR) Ι Sept. 29 (Sponsor)
Amount & Project Period: Limited to below $500,000/yr. (Direct Costs). - 5 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
FOA Link: PAR-15-085
Florida Blue Foundation

August 31 All Faculty Ranks Non-federal Health Disparities

Florida Blue Foundation
Improve Consumer Health

The Improve Consumer Health program focuses on healthy lifestyles to promote better health for families and communities.  There are two funding areas: 
Awareness and preventive projects designed to educate populations in need* about mental and behavioral health;
OR
Projects designed to train and create materials to assist populations in need* to navigate the health care system and take control of their health.

*For the purpose of this program, the term populations in need is defined as Floridians who are underserved, underinsured or low-income.
Due Dates: Aug. 29 (OSR) Ι Aug. 31 (Sponsor)
NOTE:  There will be Application Clarification Conference Calls on July 21st 10:30 a.m. - 11:30 a.m. & July 24th 10:00 a.m. - 11:00 a.m.  To participate, dial toll-free: 1-800-882-3610. The pass code is 2871940#.
Amount & Project Period: $80,000 - $100,000 - 2 or 3 years
Eligibility: All Faculty Ranks
Contact: Office of Sponsored Research (x6804)   
Links: Florida Blue Foundation  Ι Applications



September 01 See  Below Non-Federal Informatics

PhRMA Foundation - Informatics

The goal of the Informatics program is to promote development and use of novel informatics in an integrative approach toward understanding normal processes of human biology and disease processes.  
Due Dates: Aug. 30 (OSR) Ι Sept. 1 (Sponsor)
Contact: Office of Sponsored Research (x6804)

Post-Doctoral Fellowships

Amount & Project Period: $40,000/yr. (Stipend only) - Funding is for up to two years, but not beyond the third year of the existing post doctorate.
Eligibility: Applicants must 1) hold a Ph.D. in a field of study logically or functionally related to the proposed post-doctoral activities or 2) expect to receive the Ph.D. before activating the award.
All applicants must be U.S. citizens or permanent residents.
Links: Informatics Ι Post-Doctoral Fellowships

Research Starter Grants

Amount & Project Period: $100,000 - 1 year
Eligibility: Those holding tenure track position of assistant professor or research track research assistant professor appointment (i.e., not instructor) 
All applicants must be U.S. citizens or permanent residents.
Links Informatics Ι Research Starter Grants




September 01 All Ranks Non-Federal Clinical Oncology

Hope Foundation
Impact Award

This award is a funding program from the Hope Foundation that encourages novel and innovative SWOG research by supporting early and conceptual stages of such projects. Proposed work should use resources from completed SWOG trials or be directly translatable to future clinical trials in SWOG and the National Clinical Trials Network (NCTN). Studies may involve scientific risk but potentially lead to a breakthrough in a particular area, or to development of novel techniques, agents, methodologies, models, or applications that could have a major impact on cancer research.
Due Dates: Aug. 30 (OSR) Ι Sept. 01 (5:00, pm ET) (Sponsor)
Next Due Date:  March 01, 2018
Amount & Project Period: Up to $250,000 (TOTAL) - 2 years
Eligibility: Any SWOG member investigator eligible for NIH funding is encouraged to submit to this program.
Basic Science applicants are required to partner with a clinician as a Co-PI.
Contact: Office of Sponsored Research (x6804)
Links: Impact Award Ι 2017 RFA
DP1 NIH
NIH Common Fund
September 01 All Ranks Federal Non-Specific

NIH Director's Pioneer Award Program

This program complements NIH's traditional, investigator-initiated grant programs by supporting individual scientists of exceptional creativity who propose pioneering and possibly transforming approaches to addressing major biomedical or behavioral challenges that have the potential to produce an unusually high impact on enhancing health, lengthening life, and reducing illness and disability. To be considered pioneering, the proposed research must reflect substantially different scientific directions from those already being pursued in the investigator's research program or elsewhere.
Due Dates: Aug. 30 (OSR) Ι Sept. 01 (Sponsor)
Amount & Project Period: $700,000/yr. (Direct Costs) - 5 years
Eligibility: All Ranks - Only single PD/PI applications are allowed. Applications with multiple PD(s)/PI(s) will not be accepted.
Contact: Office of Sponsored Research (x6804)
RFA Link: RFA-RM-17-005
R01 NIH
NCI is a participating Institute

NEW
September 05 (LOI) All Ranks Federal Assay Development

Assay development and screening for discovery of chemical probes or therapeutic agents

The purpose is to stimulate research in discovery and development of novel, small molecules for their potential use in studying disease treatment; and to generate new insight into the biology of relevant diseases and processes that have yet to be validated as important drug targets. Stages of discovery research covered by this FOA include: 1) assay development; 2) primary screen implementation to identify initial screening hits (high throughput target-focused screens, or moderate throughput screens); 3) hit validation using a series of assays and initial medicinal chemistry inspection to prioritize the hit set.
Due Dates: Letter of Intent is due 30 days prior to submission date  
Oct. 03 (OSR) Ι Oct. 05 (Sponsor) 
Additional Due Dates:  Standard dates 
Amount & Project Period: Application budgets are not limited - 4 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
FOA Link: PAR-17-438





September 05 (LOI) All Ranks Non-Federal Translational Research

SU2C Dream Team Translational Research Grant

This initiative will fund a translational cancer research project that will address critical problems in patient care, including prevention strategies for those at risk, and deliver near-term patient benefit through investigation by a multidisciplinary, multi-institutional, collaborative Dream Team of expert investigators.  The ideas may focus on particular organ sites, patient populations (such as pediatrics) or on innovative methods of treatment. 
Due Dates: Sept. 05 (Letter of Intent)
Invited Applications:  Jan. 12 (OSR) Ι Jan. 16, 2018 (Sponsor)
Amount & Project Period: $3,000,000.00 - 3 years
Eligibility: All Faculty Ranks - Multi-investigator, multi-institutional projects are required.
Contact: Office of Sponsored Research (x6804)
Link: Overview| proposalCENTRAL
R01 NCI

September 06 (LOI) All Ranks Federal Health Disparities

Leveraging Population-based Cancer Registry Data to Study Health Disparities

The goal is to efficiently use the existing cancer registry infrastructure by augmenting data already collected with additional information needed to understand health disparities among people diagnosed with cancer. Specifically, this FOA will support the study of factors influencing observed health disparities within the framework of population-based cancer registries by the inclusion of data not routinely collected by or linked to the registries.
Due Dates: Letter of Intent requested 30 days prior to due date
Oct. 13 (OSR) Ι Oct. 16 (Sponsor)
Additional Due Dates:  Standard dates
Amount & Project Period: Application budgets are not limited - 5 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
FOA Link: PA-17-289
Companion FOA: PA-17-288 (R21)



September 06 See Below Non-Federal Mantle Cell Lymphoma

Lymphoma Research Foundation
2018 Grant Applications

Due Dates: Sept. 01 (OSR) Ι Sept. 06 (Sponsor)
Contact: Office of Sponsored Research (x6804)
Primary Link: Available Grant Opportunities
proposalCENTRAL (Submission Site)
 

Clinical Investigator Career Development Award (CDA)

This program is designed to support physician investigators at the level of advanced fellow or junior faculty member who will contribute to the development of new lymphoma therapies and diagnostic tools.
Amount & Project Period: $225,000 over 3  years
Eligibility: Must have no greater than five years of experience beyond completion of their fellowship or postdoctoral training (the five year limit may be non-sequential in cases of pregnancy or illness).
Link: Guidelines and General Instructions for Application
 

Postdoctoral Fellowship Grant

This award is designed to support investigators at the level of advanced fellow or postdoctoral researcher in laboratory or clinic based research with results and conclusions that must be clearly relevant to the treatment, diagnosis or prevention of Hodgkin and/or non-Hodgkin lymphoma. Areas of research may include, but are not limited to, etiology, immunology, genetics, therapies and transplantation.  
Amount & Project Period: $105,000 over 2  years
Eligibility: Must hold an MD, PhD, or equiv. degree.
MD Applicants must have completed at least two years (24 months) fellowship work at start of award period (March 1, 2018).
All applicants should not have completed more than five years (60 months) of fellowship or postdoc work at start of award period. Individuals holding faculty positions prior to March 1, 2018 are not eligible to apply;
Awarded applicants may move into faculty positions during award period.
Must spend 80% of their time in research during award period.
Link: Guidelines and General Instructions for Application
 

Lymphoma Clinical Research Mentoring Program (LCRMP)

The LCRMP is an education and mentoring program for fellows and junior faculty with a focus in clinical research in the field of non-Hodgkin and Hodgkin lymphoma.
Amount & Project Period: $5,000/yr. - 2 years
Eligibility: Applicant must be a junior faculty member in first four years of a faculty position or trainees at least in the second year of one of the following ACGME accredited sub-specialty fellowship programs: Hematology/Oncology, Hematology, Medical Oncology, Radiation Oncology, or Hematopathology.
Applicants should not be more than four years beyond completion of fellowship or more than twelve years beyond completion of their MD or equivalent degree.
Studies or proposals that are exclusively laboratory based are not appropriate for the LRF LCRMP.  Proposals must involve clinical observation of human subjects and may include study or development of new diagnostic methods, therapies, and/or outcome measurements directed to patients with lymphoma are required.
Link: 2018-2020 Program Overview, Guidelines and Instructions for Application
 

Adolescent/Young Adult (AYA) Lymphoma Correlative Studies

This RFA seeks proposals for correlative clinical/translational studies in adolescent/ young adult (AYA) lymphomas.  Applications may focus on either biomarkers and the biology of AYA lymphomas, or clinical outcomes/survivorship and health services studies which specifically impact the AYA lymphoma population.
Amount & Project Period: $100,000 - 2 years
Eligibility: All Faculty Ranks
Link: Guidelines and General Instructions for Application
 

Mantle Cell Lymphoma (MCL) Therapeutic Studies

This RFA seeks proposals for clinical/translational studies, including correlative studies, in mantle cell lymphoma (MCL). Applications should relate to work in the clinical setting and/or involve primary MCL patient samples. Proposals which are adjunct to an existing research project in MCL are strongly encouraged.
Amount & Project Period: $250,000 - 3 years
Eligibility: All Faculty Ranks
Link: Mantle Cell Lymphoma (MCL) Therapeutic Studies Grant RFP
R01 NIH
NCI is a participating Institute

NEW
September 07 All Ranks Federal HIV/AIDS and Aging

Multidisciplinary Studies of HIV/AIDS and Aging

The purpose of this FOA is to invite applications proposing to study HIV infection, HIV-associated conditions, HIV treatment, and/or biobehavioral or social factors associated with HIV/AIDS in the context of aging and/or in older adults. Research approaches of interest include clinical translational, observational, and intervention studies in domestic and international settings.
Due Dates: Sept. 05 (OSR) Ι Sept. 07 (Sponsor)
Additional due dates:  Standard Dates
Amount & Project Period: Application budgets are not limited - 5 yr
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
FOA Link: PAR-15-280
Companion FOA: PA-15-281 (R03)   
PA-15-282 (R21)



September 07 (LOI) See Below Federal Team Science

Concern Foundation
The Conquer Cancer Now Award

Proposals must be hypothesis-driven and centered on cancer genetics, cancer biology, or cancer immunology. Concern will not fund clinical trials, cancer epidemiology, or behavioral studies.
Due Dates: Sept. 07 (Letter of Intent)
Invited Applications:  Dec. 05 (OSR) Ι Dec. 07 (Sponsor)
Amount & Project Period: $120,000 - 2 years
Eligibility: Junior faculty - independent at the start of scientific career and at level of Asst. Professor (or equiv. with explanation)
Contact: Office of Sponsored Research (x6804)
Link: Grant Guidelines Ι proposalCENTRAL (For description, guidelines, and submissions)
DP2 NIH
NIH Common Fund
September 08 Junior Faculty Federal Career Development

NIH Director's New Innovator Award Program

This program supports a small number of early stage investigators of exceptional creativity who propose bold and highly innovative new research approaches that have the potential to produce a major impact on broad, important problems in biomedical and behavioral research.
Due Dates: Sept. 06 (OSR) Ι  Sept. 08 (Sponsor)
Amount & Project Period: $1,500,000 (Direct Costs) - 5 years
Due to multi-year funding reporting requirements, projects must end June 30, 2023.
Eligibility: Applicants must meet definition of an Early Stage Investigator (ESI) at time of application.
Applicants must hold an independent research position as of September 1, 2018.
Applicants may submit or have an R01 (or other equivalent) grant application pending concurrently that does not overlap substantially.
However, if that pending grant is awarded prior to the NIH Director's New Innovator Award, then the applicant is no longer eligible to receive the New Innovator Award.
Contact: Office of Sponsored Research (x6804)
RFA Link: RFA-RM-17-006



September 12 (Pre-Application) Junior Faculty Federal Career Development

Peer Reviewed Cancer Research Program (PRCRP)  
Career Development Award
W81XWH-17-PRCRP-CDA

The PRCRP Career Development Award supports independent, early-career investigators to conduct impactful research with mentorship of an experienced cancer researcher as an opportunity to obtain funding, guidance, and experience necessary for productive, independent careers at the forefront of cancer research. Preliminary data are not required. However, logical reasoning and a sound scientific rationale for the proposed research must be demonstrated.
Due Dates: Sept. 12 (Pre-application)
Full Applications Due:  Sept. 26 (OSR) Ι Sept. 28 (Sponsor)
Amount & Project Period: $360,000 (Direct Costs) - 3 years
Eligibility: Must be independent, early-career researcher or physician-scientist w/in 10 years of completing terminal degree (excl. time in residency or on family medical leave)
Minimum of 30% protected time required for proposed research (more protected time is highly desirable)
Designated Mentor must hold position at or above Associate Professor (or equiv.)
Contact: Office of Sponsored Research (x6804)
Link: W81XWH-17-PRCRP-CDA


September 12 All Ranks Federal Biomedical Big Data

Joint NSF/NIH Initiative on Quantitative Approaches to Biomedical Big Data (QuBBD)

This program is designed to support research that addresses important application areas at the intersection of the biomedical and data sciences by encouraging inter- and multi-disciplinary collaborations that focus on innovative and transformative approaches to address these challenges.
Due Dates: Sept. 08 (OSR) Ι Sept. 12 (Sponsor)
Amount & Project Period: $200,000 to $300,000/yr.  (Total) - 3 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
Link: 16-573 | Program Page
R01 NCI

September 12 (LOI) All Ranks Federal Health Disparities

U.S. Tobacco Control Policies to Reduce Health Disparities

The purpose of this FOA is to support observational or intervention research focused on reducing health disparities in tobacco use in the U.S.  Specifically, it is intended to stimulate scientific inquiry focused on innovative tobacco control policies.
Due Dates: Sept. 12 (Letter of Intent)
Oct. 09 (OSR) Ι Oct. 11 (Sponsor)          
Additional due dates:  June 13, & October 11, 2018
Amount & Project Period: Application budgets not limited - 5 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
Link: PAR-17-217
Companion FOA: PAR-17-218 (R21)
U01 NIH
NCI is a participating institute


September 13 (LOI) All Ranks Federal Genomics

Expanding Genome Integrity Assays to Population Studies

The FOA will support development and pilot testing of assays, such as DNA repair capacity or mutation detection, that will facilitate the wider use of genome integrity investigation in epidemiological and population studies.
Due Dates: Sept. 13 (Letter of Intent)
Applications Due:  Oct. 11 (OSR) Ι Oct. 13 (Sponsor)
Amount & Project Period: NCI:  $700,000 - 5 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
RFA Link: RFA-ES-17-006



September 13 (Pre-application) All Ranks Federal Lung

Congressionally Directed Medical Research Programs
Lung Cancer Research Program (LCRP)
Career Development Award
W81XWH-17-LCRP-CDA

This mechanism supports early-career, independent investigators to conduct impactful research under the mentorship of an experienced lung cancer researcher as an opportunity to obtain the funding, mentoring, and experience necessary for productive, independent careers at the forefront of lung cancer research. This award is intended to support impactful research projects with an emphasis on discovery.
Due Dates: Sept. 13 (Pre-application)
Full Applications Due:  Sept. 25 (OSR) Ι Sept. 27 (Sponsor)
Amount & Project Period: $250,000 (Direct Costs) - 2 years
Eligibility: Must be an independent investigator at the level of Assistant Professor, Instructor, or equivalent w/in 5 years of first faculty appointment (or equiv.) by application submission;. Must have at least 40% of protected time for lung cancer research;
Must not have received a CDMRP Career Development Award (or equiv.) from any program within the CDMRP;
Must not have received more than $300,000 in total direct costs for previous or concurrent lung cancer research as a PI of one or more Federally or privately funded, non-mentored, peer-reviewed grants.
Contact: Office of Sponsored Research (x6804)
Link: W81XWH-17-LCRP-CDA


NEW
September 15 All Ranks Non-Federal Systems Biology

Amyloidosis Foundation
2018 Research Grants

These grants support research for junior research scientists whose research targets the challenges in the field of amyloidosis.
Due Dates: Sept. 13 (OSR) Ι Sept. 15 (Sponsor)
Amount & Project Period: $50,000 - 1 year
Eligibility: Must have completed doctoral studies or clinical fellowship w/in 10 years prior to application
Contact: Office of Sponsored Research (x6804)
Link: Grant Programs



September 15 Junior Faculty Non-Federal Career Development

Alfred P. Sloan Foundation  
Sloan Research Fellows

The Sloan Research Fellowships seek to stimulate fundamental research by early-career scientists and scholars of outstanding promise.  
Due Dates: Sept. 13 (OSR) Ι Sept. 15 (Sponsor)  
Amount & Project Period: $65,000 - 2 years
Eligibility: Must hold a tenure track (or equiv.) position Tenure track faculty positions must include a yearly teaching requirement.
Must hold a Ph.D. (or equiv.) in chemistry, computational or evolutionary molecular biology, computer science, economics, mathematics, neuroscience, physics, or a related field;
Candidates' most recent Ph.D. (or equiv.) must have been awarded on or after September 1, 2011.  Exceptions may apply. 
Contact: Office of Sponsored Research (x6804)
Link: Sloan Research Fellowships




September 15 PostDocs/Junior Faculty Non-Federal Career Development

The Lung Cancer Foundation of America (LCFA) and the International Association for the Study of Lung Cancer (IASLC)
Lori Monroe Scholarship in Translational Lung Cancer Research

Applications addressing the following research areas will be given priority:
1) Facilitating the collaboration, information-sharing and interaction between basic researchers and clinical investigators with the goal of expediting and translating results of scientific investigation into clinical practice to reduce the burden of lung cancer; or
2) Exploring innovative models of lung cancer care delivery; or
3) Exploring the etiologies of lung cancer in the never smoker population.
Due Dates: Sept. 13 (OSR) Ι Sept. 15 (Sponsor)
Amount & Project Period: $200,000 - 2 years
Eligibility: Applicant must hold a doctoral degree and full-time faculty appointment, and have completed a training fellowship. Award targets junior and midlevel investigators, defined as less than 7 years from first tenure-track appointment, at the assistant or associate professor level.
Applicant's institution must agree to not less than 50% of "protected time" for the applicant to dedicate to research.
Contact: Office of Sponsored Research (x6804)
Link: Grant Opportunity

September 15 (Abstract) See Specific Award Below Non-federal Career Development

Leukemia & Lymphoma Society
Career Development Program (CDP)

The purpose of the CDP is to enhance the careers of scientists researching blood cancer or normal blood cell biology that has relevance to blood cancer.  LLS offers the opportunity to take part in translational, basic and clinical research, as well as technological and informatics development; however, all approaches must have direct blood cancer relevance.
Due Dates: Jul.  01 - Sept. 01 (Eligibility must be confirmed by 09/01)
Sept. 15 (Abstracts due)
Full Applications Due:  Sept. 29 (OSR) Ι Oct. 03 (Sponsor)
Contact: Office of Sponsored Research (x6804)
Primary Link: Career Development Program
 

Scholar

A Scholar will be a highly qualified investigator w/a capacity for independent, sustained original investigation in hematologic malignancies. Should have obtained substantial research support from a national agency.
Amount & Project Period: $110,000/yr. - 5 years
Eligibility: Must hold independent faculty position w/start date on or after 1/1/2010;
Must have R01-level funding (Substantial, peer-reviewed extending beyond July 1, 2018; must be PI on this funding)
 

Scholar in Clinical Research

A Scholar in Clinical Research is conducting original, independent applied research, often involving early-stage clinical trials that will advance the prevention, diagnosis or treatment of hematologic malignancies.
Amount & Project Period: $125,000/yr. - 5 years
Eligibility: Must hold independent faculty position w/start date on or after 1/1/2008;
Expected to have concomitant support for research from another source or agency;
Must have protected research time in the range of 20%-40%
 

Special Fellow

A Special Fellow is qualified investigator who's completed a minimum of 2 years of postdoctoral research training and is continuing a mentored research position. The intention is to begin to transition to an independent research program.
Amount & Project Period: $67,000/yr. -  2 or 3 years
Eligibility: For a 2 Year Award:  Oral thesis defense on or after 7/1/2013
For a 3 Year Award:  Oral thesis defense on or after 7/1/2014 More details are contained in the Guidelines & Instructions. Sponsor must have R01-level funding (Substantial, peer-reviewed extending beyond July 1, 2018; must be PI on this funding)
 

Fellow

A Fellow is a promising investigator w/less than 2 years of postdoc research training. The intention is to encourage an academic career involving clinical or fundamental research in hematologic malignancies under a research sponsor's direction. Proposal must be directly relevant to hematological malignancies and/or relevant pre-malignant conditions.
Amount & Project Period: $60,000 - 3 years
Eligibility: Oral thesis defense on or after 1/1/2016
Degree must be conferred by Award start date of July 1, 2018
Sponsor must have R01-level funding (Substantial, peer-reviewed extending beyond July 1, 2018; must be PI on this funding)
More details are contained in the Guidelines & Instructions.
R01 NIH

September 15 All Ranks Federal Non-Specific

NIH Director's Transformative Research Awards

This program complements NIH's traditional, investigator-initiated grant programs by supporting individual scientists or groups of scientists proposing groundbreaking, exceptionally innovative, original and/or unconventional research.  Applications supported under this award will reflect ideas substantially different from mainstream concepts.  Requirements for explicitly addressing specific issues, focuses attention on the importance of the problem, the novelty of the hypothesis and/or the proposed methodology, and the magnitude of the potential impact rather than on preliminary data or experimental details, rather than on preliminary data or experimental details.
Due Dates: Sept. 13 (OSR) Ι Sept. 15 (Sponsor)
Amount & Project Period: Application budgets not limited - 5 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
RFA Link: RFA-RM-17-007
R03 NIH
NCI is a participating Institute

NEW
September 18 All Ranks Federal Tobacco

Tobacco Regulatory Science Small Grant Program for New Investigators

The purpose of this FOA is to invite applications to support biomedical and behavioral research that will provide scientific data to inform regulation of tobacco products to protect public health. This grant mechanism will support different types of projects including pilot and feasibility studies; secondary analysis of existing data; small, self-contained research projects; development of research methodology; and development of new research technology. 
Due Dates: Letter of Intent requested 30 days prior to due date
Sept. 14 (OSR) | Sept. 18 (Sponsor)
Additional due dates:  Feb. 13, 2018; July 17, 2018; Feb. 13, 2019
Amount & Project Period: $50,000/yr (Direct Costs) - 2 years  
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
FOA Link: RFA-OD-17-012
R01 NIH
NCI is a participating Institute

NEW
September 18 All Ranks Federal Tobacoo

Tobacco Regulatory Science

The purpose of this FOA is to invite applications to support biomedical and behavioral research that will provide scientific data to inform regulation of tobacco products to protect public health. Research Projects must address the research priorities related to the regulatory authority of the Food and Drug Administration (FDA) Center for Tobacco Products (CTP).
Due Dates: Letter of Intent requested 30 days prior to due date
Sept. 14 (OSR) | Sept. 18 (Sponsor) 
Additional due dates:  Feb. 13, 2018; July 17, 2018; Feb. 13, 2019
Amount & Project Period: $300,000/yr (Direct Costs) - 3 years  
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
FOA Link: RFA-OD-17-013
Companion FOA: RFA-OD-17-014 (R21)

September 18 (Pre-application) PostDocs Non-federal Career Development

The Hope Funds for Cancer Research
The Postdoctoral Fellowship

The purpose is to provide fellowships to postdoctoral scientists who propose to work on highly innovative research projects that challenge the traditional paradigms of understanding the causes, mechanisms, progression, disease markers or risk factors of the most difficult-to-treat cancers, including pancreatic, lung, liver, sarcomas, esophageal, brain, gastric, bone and ovarian cancers; and rare leukemias, lymphomas and MDS.
Due Dates: Sept. 18 (Pre-application)
Invited Applications:  Jan. 16 (OSR) Ι Jan. 14, 2018
Amount & Project Period: Stipend: $48,000/yr.01; $50,000/yr.02; and $52,000/yr.03.
A travel grant of $1,500 will be awarded annually to support attendance at  conferences and/or scientific training meetings.
Eligibility: Must have completed 1 or more of the following degrees or its equiv.: MD, PhD, MD/PhD, DDS, DVM. For foreign-trained physicians, equivalency determined on a case-by-case basis. Candidates must conduct proposed research under a sponsor w/a formal appointment at host institution.
Candidates can apply prior to starting or during their postdoctoral appointments provided they have been formally accepted into the lab from which they apply, and current postdoctoral scientists must not have been in their Sponsor's lab for > 2 years as of Sept. 18, 2016.
Contact: Office of Sponsored Research (x6804)
Link: Fellowship Award Eligibility & Application Instructions


&

NIGMS NIH

September 18 All Ranks Federal Biomedical Mathematics

Joint DMS/NIGMS Initiative to Support Research at the Interface of the Biological and Mathematical Sciences (DMS/NIGMS)

The purpose is to support research in mathematics and statistics on questions in the biological and biomedical sciences. Both agencies recognize the need for promoting research at the interface between the mathematical sciences and the life sciences. This program is designed to encourage new collaborations, as well as to support existing ones.
Due Dates: Sept. 15 (OSR) Ι Sept. 18 (Sponsor)
Amount & Project Period:  $100,000 to $400,000/yr. (Total Costs) - 3 to 5 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
Link: NSF 17-569


September 19, Noon (Concept Paper) Postdocs/Junior Faculty Non-Federal Career Development

Thrasher Research Fund
Early Career Grants 2017 Fall Cycle

The purpose of this program is to encourage the development of medical research in child health by awarding small grants to new researchers, helping them gain a foothold in this important area. There is no focus on a particular disease.
Due Dates: Sept. 19 (Concept paper)
Invited Applications:  Oct. 04 (OSR) Ι Oct. 06 (Sponsor)
Amount & Project Period: $25,000 (Direct Costs) - 1 to 2 years
Eligibility: Physicians in a residency/fellowship training program or have completed program < 1 year before date of submission of Concept Paper.
Post-docs who received doctoral level degree < 3 years prior date of submission of Concept Paper.
A new investigator who holds an NIH K award or a CTSA is not eligible.
There are no restrictions with regard to citizenship.
Mentors may have only one Thrasher Research Fund Early Career Awardee at a time.
Contact: Office of Sponsored Research (x6804)
Link: Early Career Awards


NEW
September 21 All Ranks Non-federal Career Development

Conquer Cancer Foundation
Grants & Awards

 
Due Dates: Sept. 19 (OSR) Ι Sept. 21 (Sponsor)
Contact: Office of Sponsored Research (x6804)
Primary Link: Funding Opportunities
 

Career Development Award

This award provides research funding to clinical investigators, who have received their initial faculty appointment, as they work to establish an independent clinical cancer research program. Research must have a patient-oriented focus, including a clinical research study and/or translational research involving human subjects. Proposals with a predominant focus on in vitro or animal studies (even if clinically relevant) are not allowed.
Amount & Project Period: $200,000 - 3 years
Eligibility: Be a physician (MD, DO or international equiv.) in 1st to 3rd year of a full-time primary faculty appointment in a clinical department at an academic medical institution at proposal submission.   Faculty appointment may begin w/entry-level faculty position;
Have completed productive postdoctoral research and demonstrated the ability to undertake independent investigator-initiated clinical research;
Be an ASCO Member or have submitted a membership application w/application. To apply for membership, or to renew existing membership, please visit http://www.asco.org/membership.  
Be able to commit more than 50% of full-time effort in research (applies to total research, not just the proposed project) during award period.
See Eligibility for additional detail.
Link: Career Development Award
 

Young Investigator Award

This award provides funding to promising investigators to encourage and promote quality research in clinical oncology. The purpose of this grant is to fund physicians during the transition from a fellowship program to a faculty appointment.
Amount & Project Period: $50,000 - 1 year
Eligibility: Be a physician (MD, DO, or international equiv.) currently in last 2 years of final subspecialty training and w/in 10 years of obtaining medical degree at time of proposal submission;
An MD, PhD is eligible if both degrees are completed prior to start of grant period.
Be planning an investigative career in clinical oncology.
Be an ASCO member or have submitted a membership application w/application. To apply for membership, or to renew existing membership, please visit http://www.asco.org/membership.
Be able to commit at least 60% of full- time effort in research (applies to total research, not just proposed project) during award period.
See Eligibility for additional detail.
Link: Young Investigator Award


NEW
September 22 (LOI) Established Investigators Non-federal Hematological Malignancies

Leukemia & Lymphoma Society
Specialized Center of Research (SCOR)

The overall goal of this mechanism is to enhance the development of innovative strategies for the treatment, diagnosis or prevention of hematological malignancies. To bring together established investigators from one or several institutions to develop a focused research program and enhance interdisciplinary research. There must be objective evidence of interdisciplinary research among the Projects and Cores.
Due Dates: Sept. 22 (Letter of Intent)
Invited Applications: Mar. 01 (OSR) Ι Mar. 3 (Sponsor)
Amount & Project Period: $1,000,000/yr. (TOTAL) - 5 years
Eligibility: Must hold a PhD, MD, DVM or equivalent and be affiliated with a non-profit institution
Contact: Office of Sponsored Research (x6804)
Links: Overview | Fluxx (Research Portal)
R21 NCI

NEW
September 26 All Ranks Federal Molecular & Cellular Analysis

Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer

This FOA solicits grant applications proposing exploratory research projects focused on the early-stage development of highly innovative technologies offering novel molecular or cellular analysis capabilities for basic or clinical cancer research. The emphasis of this FOA is on supporting the development of novel capabilities involving a high degree of technical innovation for targeting, probing, or assessing molecular and cellular features of cancer biology.
Due Dates: Letter of Intent requested 30 days prior to due date.
Sept. 22 (OSR) Ι Sept. 26 (Sponsor)
Amount & Project Period: $400,000 (Direct Costs) - 3 years  
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
FOA Link: RFA-CA-17-010
Companion FOA: RFA-CA-17-011 (R33)
R21 NCI

NEW
September 26 All Ranks Federal Biospecimen

Innovative Technologies for Cancer-Relevant Biospecimen Science

This FOA solicits grant applications proposing exploratory research projects focused on the early-stage development of highly innovative technologies that improve the quality of the samples used for cancer research or clinical care. It will support the development of tools, devices, instrumentation, and associated methods to preserve or protect sample integrity, or establish verification criteria for quality assessment/quality control and handling under diverse conditions.
Due Dates: Letter of Intent requested 30 days prior to due date.
Sept. 22 (OSR) Ι Sept. 26 (Sponsor)
Amount & Project Period: $400,000 (Direct Costs) - 3 years  
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
FOA Link: RFA-CA-17-012
Companion FOA: RFA-CA-17-013 (R33)


September 29 (LOI) All Faculty Ranks Non-federal Blood Cancers/Translational

Leukemia & Lymphoma Society
Translational Research Program (TRP)

This program funds new and innovative research that shows high promise for translating basic biomedical knowledge to clinical application.  The goal of translational research is to reduce the time between laboratory findings and actual treatment.
Due Dates: Sept. 29 (Letter of Intent)
Full Applications:  Nov. 13 (OSR) Ι Nov. 15 (Sponsor)
Amount & Project Period: $200,000/yr. (Total) - 3 years
Eligibility: All Faculty Ranks
Contact: Office of Sponsored Research (x6804)
Links: TRP application process | FLUXX (Research Portal)


September 30 All Ranks Federal Medical Research


Department of Defense - Dept. of the Army - USAMRAA
DoD USAMRMC FY17 Broad Agency Announcement
for Extramural Medical Research
XW1XWH-17-R-BAA1

Projects funded under this BAA must be for basic and applied research to support scientific study and experimentation directed towards advancing the state of the art or increasing knowledge or understanding rather than focusing on development of a specific system or hardware solution.
Due Dates: This Broad Agency Announcement (BAA) is open from October 1, 2016 through September 30, 2017, 11:59 p.m., ET. Pre-proposals are required so that the Government can determine whether a proposed research idea meets USAMRMC's mission and requirements. Pre-proposals may be submitted at any time during the 12-month period.  To submit a full proposal/application, the PI must have received an invitation to submit from a Contracting or Grants Officer.
Amount & Project Period: No  funding limitations specified - 4 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
Link: W81XWH-17-R-BAA1


NEW
October 01 Postdocs Non-Federal Immunology

Cancer Research Institute
CRI Irvington Postdoctoral Fellowship

The CRI Irvington Postdoctoral Fellowship Program supports qualified young scientists who wish to receive training in cancer immunology. The Institute seeks hypothesis-driven, mechanistic studies in both immunology and tumor immunology that directly impacts our understanding of the immune system’s role in cancer risk, tumor initiation, progression, metastasis, host response to tumor and/or the treatment of cancer.
Due Dates: Sept. 28 (OSR) Ι Oct. 01 (Sponsor)
Amount & Project Period: Funding is comprised of a progressive stipend starting at $55,000 and Expense allowance  ($1,500) – 3 years
Eligibility: Must be working in areas directly related to cancer immunology.  
Must have a doctoral degree by date of award activation and must conduct their proposed research under a sponsor who holds a formal appointment at the host institution.
Must not have 5 or more years of relevant postdoctoral experience, with the exception of M.D. applicants, who should not include years of residency in this calculation. ·
Must not have 3 or more years in a sponsor’s laboratory by the start date of fellowship.
Contact: Office of Sponsored Research (x6804)
Link: Guidelines  Ι  Application Instructions

October 01 Junior Faculty Non-Federal Career Development

Research Foundation of the American Society of Colon and Rectal Surgeons
Career Development Award

This award focuses on career development and mentorship of the individual rather than solely on the research proposal. The award is intended for the academic investigator demonstrating significant creativity in research relevant to the pathophysiology or management of diseases of the small bowel, colon, rectum, or anus.
Due Dates: Aug. 03 (OSR) Ι Oct. 01 (Sponsor)    
Next Semi-annual Due Date: March 01
Amount & Project Period: $150,000 - 2 years
Eligibility: Must be w/in 5 years of first full-time faculty appointment; Must be a U.S. or Canadian citizen who has completed an approved colorectal surgery training program; and be a member of ASCRS;
Must not currently have or have previously received a career development award
Contact: Office of Sponsored Research (x6804)
Link: Application Instructions



October 01 PostDocs/New Investigators Non-federal Regenerative Medicine and Cell Therapy

The Sartorius & Science Prize for Regenerative Medicine and Cell Therapy

This prize is focused on basic or translational research that advances regenerative medicine and cell therapy that advances regenerative medicine and cell therapy; for example cell-, gene-, or immunotherapy, tissue engineering, and materials engineering.
Due Dates: Oct. 01 (Sponsor)
Amount & Project Period: Cash prize of $25,000 and a publication of essay in Science Online.  Winners also receive a 5-year membership to the American Association for the Advancement of Science (AAAS).
Eligibility: Entrant must have an advanced degree received on or after January 1, 2007. Candidates for MD/PhD degrees are eligible if either their Ph.D. or final degree was awarded after January 1, 2007;
Entrant must have performed the work described in the essay.
Contact: sartoriusscience@aaas.org
Links: Overview |  How to Enter




October 01 (LOI) All Faculty Ranks Non-federal Blood Cancers/Translational

Rising Tide Foundation for Cancer Research and Leukemia & Lymphoma Society
RTFCCR/LLS Patient-Focused Prevention

The Rising Tide Foundation for Clinical Cancer Research and the Leukemia & Lymphoma Society offer this competitive grant to advance breakthroughs in prevention for blood cancers.  There are 4 RFP-suggested topics:  Clinical Trials, Biomarker Evaluation, Use of Experimental Systems, and Drug the Undruggable described at the program site. 
Grants must be translational in nature and ideally will have a clinical trial proposed, or could lead to a clinical trial. Applications that are solely laboratory-based without consideration of using patient samples or future clinical testing will not be accepted for review.
Due Dates: Oct. 31 (Letter of Intent)
Full Applications:  Jan. 30 (OSR) Ι Feb. 01, 2018 (Sponsor)
Amount & Project Period: $0.6 - 1.2 M
Eligibility: All Faculty Ranks  
Contact: Office of Sponsored Research (x6804)
Sponsor Contact: Eveline Mumenthaler, Director of RTFCCR (Eveline.mumenthaler@risingtide.ch) or
Lee Greenberger, Chief Scientific Officer of LLS (researchprograms@lls.org)
Links: Academic Grants
Patient-focused Prevention
proposalCENTRAL (Submission Site)



October 03 All Ranks Federal Mathematical Analysis

National Science Foundation Division of Mathematical Sciences
Analysis Program

Research supported by the Analysis Program provides the theoretical underpinning for the majority of applications of the mathematical sciences to other scientific disciplines.
Due Dates: Sept. 29 (OSR) Ι Oct. 03 (Sponsor)
Amount & Project Period: Amount not stated - 3 to 5 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
Link: PD 16-1281 | Mathematical Sciences
R01 NCI

NEW
October 05 All Ranks Federal Molecular

Using Small Molecules and Molecular Genetics to Identify Novel Targets and Mechanisms Contributing to Tumor Immune Evasion

The purpose of this FOA is to stimulate research on the identification of new and novel targets and mechanisms involved in tumor immune evasion, which may be amenable to analysis by small molecules, pharmacological, or molecular genetics approaches. A specific focus of this FOA is to encourage cross disciplinary collaborations between immunologists, cell biologists, medicinal chemists, pharmacologists, and molecular biologists.
Due Dates: Oct. 03 (OSR) Ι Oct. 05 (Sponsor)
Additional due dates:  Standard Dates
Amount & Project Period: Application budgets are not limited - 5 yrs
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
FOA Link: PA-17-330 (R01)
R01 NIH

NEW
October 05 All Ranks Federal Small Molecule

Discovery of Small Molecule Immunomodulators for Cancer Therapy

The purpose of this FOA is to promote the discovery of novel small molecules that may enhance the ability of the immune system to selectively recognize and attack cancer cells. Investigators from multiple scientific disciplines (immuno-oncology, tumor biology, screening technology, medicinal chemistry, and pharmacology) are encouraged to establish collaborative teams to discover and develop novel small molecule immunomodulators for cancer therapy.
Due Dates: Letter of Intent requested 30 days prior to due date
Oct. 03 (OSR) Ι Oct. 05 (Sponsor)
Additional due dates:  Standard Dates
Amount & Project Period: Application budgets are not limited - 4 yrs
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
FOA Link: PAR-17-331
R01 NCI

October 05 All Ranks Federal Residential History

Integration of Individual Residential Histories into Cancer Research

The purpose is to support substantive investigation of the role of individual residential histories in cancer etiology and outcomes, and to encourage the development of complex analytical strategies in support of substantive investigation.
Due Dates: Letter of Intent requested 30 days prior to due date
Oct. 03 (OSR) Ι Oct. 05 (Sponsor)
Additional due dates:  Standard dates
Amount & Project Period: Application budgets are not limited - 5 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
FOA Link: PA-17-298
Companion Link: PA-17-295 (R21)
R01 NIH
NCI is a participating Institute
October 05 All Ranks Federal HIV and Aging

Multidisciplinary Studies of HIV/AIDS and Aging  

NCI seeks to foster research studies to help understand how aging in the presence of chronic HIV infection affects the risk, spectrum and biology of cancer (AIDS-defining and non-AIDS-defining cancers).
Due Dates: Oct. 03 (OSR) Ι Oct. 05 (Sponsor)
Additional Due Dates:  Standard dates
Amount & Project Period: Application budgets are not limited - 5 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
FOA Link: PAR-17-321
Companion FOA: PAR-17-320 (R21)


NEW
October 06 (LOI) See Below Non-Federal Melanoma

Melanoma Research Alliance
Team Science Award

This team science award is designed to foster a collaborative research process and promote transformational melanoma research advances with the potential for rapid clinical translation. It will support projects with the potential to lead to transformative advances in prevention, detection, diagnosis, staging and/or treatment of melanoma.
Due Dates: Oct. 06 (Letter of Intent)
Invited applications: Jan. 05 (OSR) Ι Jan. 09 (Sponsor)
Amount & Project Period: $900,000 (Total Costs) - 3 years  
Eligibility: Must hold a full-time faculty appointment at the level of Assistant Professor (or equivalent) or above.
Contact: Office of Sponsored Research (x6804)
Link: Overview Ι RFP
R01 NIH

October 11 All Ranks Federal Health Disparities

U.S. Tobacco Control Policies to Reduce Health Disparities

The purpose is to support observational or intervention research focused on reducing health disparities in tobacco use in the U.S. It is intended to stimulate scientific inquiry focused on innovative tobacco control policies.  Applicants may propose projects in which the primary outcome of interest is on reducing tobacco use health disparities in vulnerable populations by utilizing tobacco prevention and control strategies. 
Due Dates: Letter of Intent requested 30 days prior to due date
Oct. 09 (OSR) Ι Oct. 11 (Sponsor)
Additional due dates: June 13, 2018; Oct. 11, 2018; June 13, 2019; Oct. 11, 2019; June 15, 2020
Amount & Project Period: Application budgets are not limited - 5 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
FOA Link: PAR-17-217
PAR-17-218 (R21)



October 13 (LOI) All Ranks Non-Federal Bone Marrow Failure and Cancer

Fanconi Anemia Research Fund, Inc.
Research Grants

Supports research focusing on rapid discovery and development of therapies or strategies that treat, control, or cure Fanconi anemia.   There is particular interest in supporting interdisciplinary and translational research efforts including:
- Understanding how alteration of the Fanconi anemia genes and their products lead to the clinical manifestations of Fanconi anemia.
- Determining causes of bone marrow failure, myelodysplasia and leukemia in individuals with Fanconi anemia, and developing strategies to prevent, treat, and cure these disorders. 
- Defining the pathogenesis of Fanconi anemia-associated cancers, and developing strategies for prevention, early detection, treatment and cure.
Due Dates: Oct. 13 (Letter of Intent)
Invited Applications: Jan. 31 (OSR) Ι Feb. 02, 2018 (Sponsor)
Amount & Project Period: $150,000 - $175,000 over a two year period.
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
Link: Grant Applications
Admin Supplement NIH
NCI is a participating Institute
October 15 See Below Federal Dietary Supplements

Administrative Supplements for Research on Dietary Supplements

The purpose of these supplements is to support research in which the supplemental funding would investigate the role of dietary supplements and/or their ingredients in health maintenance and disease prevention. 
Due Dates: Oct. 13 (OSR) Ι Oct. 15 (Sponsor)
Addnl. Due Dates:  Jan. 15 and Apr. 15, 2018
Amount & Project Period: Up to $100,000 (Direct Costs) - 1 year (Must be w/in currently approved project period for existing parent award. 
Eligibility: Only active awards w/at least 18 months remaining at time of submission will be considered.  Awards in no-cost extension periods are not allowed to submit an application.  
Contact: Office of Sponsored Research (x6804)
Link: PA-17-307
R21 NIH

NEW
October 16 All Ranks Federal Health Disparities

Leveraging Population-based Cancer Registry Data  to Study Health Disparities

The goal is to efficiently use existing cancer registry infrastructure by augmenting data already collected with additional information needed to understand health disparities among people diagnosed with cancer. This FOA will support the study of factors influencing observed health disparities within the framework of population-based cancer registries by the inclusion of data not routinely collected by or linked to the registries. Studies should be hypothesis-driven and multidisciplinary approaches are encouraged. Investigators are encouraged to leverage data already collected by the registries to investigate the determinates of health disparities.
Due Dates: Oct. 12 (OSR) Ι Oct. 16 (Sponsor)
Additional due dates:  Standard Dates
Amount & Project Period: $275,000 (Direct Costs) - 2 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
FOA Link: PA-17-288
Companion FOA: PA-17-289 (R01)
R21 NIH
NCI is a participating Institute

NEW
October 16 All Ranks Federal Genomics

Ethical, Legal, and Social Implications (ELSI) of Genomics Exploratory/Developmental Research Grant Program  

The purpose of this FOA is to solicit exploratory or developmental research applications that identify, analyze, and address the ethical, legal and social implications (ELSI) of these genetic and genomic advances for individuals, families, communities and society more broadly. 
Due Dates: Oct. 12 (OSR) Ι Oct. 16 (Sponsor)
Additional due dates:  Standard Dates
Amount & Project Period: $275,000 (Direct Costs) - 2 years  
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
FOA Link: PA-17-323
Companion FOA: PA-17-324 (R03)
PA-17-325 (R01) Due date Oct 05




October 16 All Faculty Ranks Non-Federal Immunotherapy Melanoma

American Cancer Society & Melanoma Research Alliance
Understanding, Preventing, and Managing Immunotherapy-related Adverse Events (irAEs) Associated with Checkpoint Inhibition for Melanoma and Other Cancers - Pilot Award

This initiative by the American Cancer Society and the Melanoma Research Alliance will award pilot or exploratory projects whose purpose is to test interventions, develop research methodologies and explore novel areas of research leading towards reduction of immune related adverse events (irAEs) and improvement of overall outcomes for cancer patients treated with checkpoint immunotherapy.
Due Dates: Oct. 13 (OSR) Ι Oct. 16 (Sponsor)
Paper application copy due Oct. 17 (Sponsor)
Amount & Project Period: $200,000 (Total) - 2 years
Eligibility: Independent investigators at all stages 
PI must hold a doctorate degree (M.D., Ph.D., or equiv.) and have full-time faculty position or equiv.
Multiple PIs or Co-PIs are not allowed.
Contact: Office of Sponsored Research (x6804)
Link: Pilot Award Policies and Instructions (PDF)
proposalCENTRAL (submission site)


Fall Cycle
October 16 See Below Non-federal Career Development

American Cancer Society  -  Fall 2017

Due Dates: Oct. 12 (OSR) Ι Oct. 16 (Sponsor)
Note: Paper copes are due one day after submission of electronic copy
Contact: Office of Sponsored Research (x6804)
Primary  Links: Grant Types Ι proposalCENTRAL
 

Postdoctoral Fellowships

To support the training of researchers who have received a doctoral degree to provide initial funding leading to an independent career in cancer.
Amount & Project Period: Progressive stipends: $48,000, $50,000, and $52,000, plus a $4,000/yr. fellowship allowance - 3 years
Eligibility: Must be a U.S. citizen or permanent resident;
Must obtain doctoral degree prior to start date;
Cannot have held a PhD or MD for more than 4 years at time of submission
Links: Overview Ι Policies and Instructions
 

Mentored Research Scholar

The goal is to support junior faculty members to become independent investigators as either clinician scientists or cancer control researchers. This grant is for individuals whose training primarily has prepared them for a career as a clinician or to conduct clinical or cancer control research, with the goal of strengthening their capacity to conduct cancer research.
Amount & Project Period: $135,000/yr.  (Direct Costs) - 5 years
Eligibility: Must be a U.S. citizen or permanent resident
Be w/in first four years of a full time  faculty appointment or equiv. and must provide a justification that supports the need for mentoring;
May not have indepenbdent research program and/or independent extramural research funding (R01 or equiv.)
See Policies & Instructions for additional detail.
Links: Overview | Policies & Instructions
 

Research Scholar Grants (RSG)

The RSG is intended to provide the resources for investigator-initiated research in a variety of cancer-relevant areas.
Amount & Project Period: $165,000/yr. (Direct Costs) - 4 years
Eligibility: Must be a U.S. citizen or permanent resident;
Must have an independent research or faculty position and be w/in six years of first academic appointment;
See Policies & Instructions for additional detail.
Links: Overview | Policies & Instructions
 

RFA: Pilot and Exploratory Projects in Palliative Care of Cancer Patients and Their Families

Pilot/exploratory research grants in palliative care of cancer patients and their families. These grants will generate the pilot data necessary to maximize an investigator's chances of competing successfully for larger grants.
Amount & Project Period: $60,000/yr. (Direct Costs) - 2 years
Eligibility: Must be a U.S. citizen or permanent resident;
Must have a full-time faculty position or equiv.
Links: Overview| Policies & Instructions
U01 NCI

NEW
October 20 (LOi) All Ranks Federal Informatics

Early-Stage Development of Informatics Technologies for Cancer Research and Management 

For the development of enabling informatics technologies to improve the acquisition, management, analysis, and dissemination of data and knowledge across the cancer research continuum including cancer biology, cancer treatment and diagnosis, cancer prevention, cancer control and epidemiology, and/or cancer health disparities.
Due Dates: Oct. 20 (Letter of Intent)
Nov. 16 (OSR) Ι Nov. 20 (Sponsor)
Additional Due Date:  June 14, 2018
Amount & Project Period: $300,000 Direct Costs (excl. consortium F&A) - 3 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
FOA Link: PAR-15-332
Companion FOAs: PAR-15-334, R21 - Development of Innovative Informatics Methods and Algorithms for Cancer Research and Management PAR-15-331, U24 - Advanced Development of Informatics Technologies for Cancer Research and Management
PAR-15-333, U24 - Sustained Support for Informatics Resources for Cancer Research and Management
U01 NIH

NEW
October 23 All Ranks Federal Oncology/Thrombosis

Consortium Linking Oncology with Thrombosis (CLOT)

The goal is to establish a program which will provide support for the collaborative efforts of oncologists and coagulation/vascular experts to identify, further develop, and implement advances in thrombosis and hemostasis research into practice for cancer patients. The purpose of this FOA is to 1) encourage studies in selected cancer types that expand mechanistic investigation into the intersection between cancer and thrombotic pathways; and 2) apply mechanistic insights towards the identification and development of biomarkers of thrombotic risk or cancer progression and new strategies for preventing or treating the deleterious interplay between cancer, cancer therapy, and hemostasis/thrombosis.
Due Dates: Letter of Intent is due 30 days prior to submission date
Oct. 19 (OSR) Ι Oct. 23 (Sponsor)
Amount & Project Period: $500,000/yr. (Direct Costs) - 5 years  
Additional $100,000 in direct costs per year for site selected to serve as Administrative Coordinating Center.  
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
FOA Link: RFA-HL-18-021
U01 NCI

NEW
October 24 (LOI) All Ranks Federal Systems Biology

Emerging Questions in Cancer Systems Biology

This FOA invites cooperative agreement applications for Research Projects that utilize systems biology approaches to address emerging questions in cancer initiation, progression, and treatment.  Research Projects proposed in response to this FOA must demonstrate explicit integration of experimental biology and computational modeling to test and validate novel hypotheses in cancer research.
Due Dates: Oct. 24 (Letter of Intent)
Nov. 22 (OSR) Ι Nov. 24 (Sponsor)
Additional Due Date:  June 22 & Nov. 23, 2018
Amount & Project Period: Application budgets are not limited - 5 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
FOA Link: PAR-16-131



October 31 All Ranks - See Below Non-Federal Ovarian

Kaleidoscope of Hope (KOH) Ovarian Cancer Research  Foundation
2018 Request for Proposals
General Research Grants & Young Investigator Grants

Proposals in the following areas will be considered:
Early Detection of Ovarian Cancer including precursor cell studies
and
 Treatment of Ovarian Cancer. 
The following areas will not be considered: survivorship topics, patient education or care resources and awareness education. 
Due Dates: Due Dates: Oct. 27 (OSR) Ι Oct. 31 (Sponsor)
Contact: Office of Sponsored Research (x6804)
Link: RFP
 

General Grants  

Research proposals may be individual projects or part of a larger project related to ovarian cancer. Proposals for clinical trials must be original investigational studies related to ovarian cancer in which the grantee is the primary investigator (PI) or co-PI.
Amount & Project Period: $50,000 -1 year
Eligibility: Established Investigators

Young Investigator (YI) Grants

Young investigator grants support career development in the area of ovarian cancer research.
Amount & Project Period: $50,000 -1 year
Eligibility: A post-doctoral fellow or asst. professor w/in 5 years (excluding clinical training) of completing terminal degree. OR
An assistant professor (or equiv.) w/in 3 years of initiating independent research.
Must have the support of a qualified mentor




November 01 (LOI) All Faculty Ranks Non-Federal Immunotherapies

Clinic Laboratory Integration Program (CLIP)

CLIP Grants provide funding for qualified scientists who are working to explore clinically relevant questions aimed at improving the effectiveness of cancer immunotherapies. The grant will support basic, pre-clinical, and translational research, which will provide information that can be directly applied to optimizing cancer immunotherapy in the clinic.
Due Dates: Nov. 01 (Letter of Intent)
Invited Applications:  Jan. 30 (OSR) Feb. 01, 2018 (Sponsor)
Amount & Project Period: $100,000/yr. - 2 years
Eligibility: Tenure Track Assistant Professor or higher (By award activation)
No citizenship restrictions
Contact: Office of Sponsored Research (x6804)
Link: CLIP Application Guidelines


November 01 All Ranks Non-Federal Career Development

American College of Surgeons
Faculty Research Fellowships

The purpose is to provide support to surgeons entering academic careers in surgery or a surgical specialty. The fellowship is to assist a surgeon in the establishment of their research program under mentorship with the goal of transitioning to becoming an independent investigator. Applicants should have demonstrated their potential to work as independent investigators.
Due Dates: Oct. 30 (OSR) Ι Nov. 01 (Sponsor)
Amount & Project Period: $80,000 - 2 years
Eligibility: Applicant must have:
(1) Completed chief residency year or accredited fellowship training w/in preceding 5 years, not including time off for maternity leave, military deployment, or medical leave; and (2) Received a full-time faculty appointment in a department of surgery or a surgical specialty.
Applicants who have previously won an award from another professional society or NIH are not eligible.
A minimum of 50% effort must be committed to research proposed in application, and may run concurrently with effort requirements of NIH or other accepted funding.
Contact: Office of Sponsored Research (x6804)
Link: ACS Faculty Research Fellowships


NEW
November 07 All Ranks Non-federal Upper Gastrointestinal Malignancies

DeGregorio Family Foundation
8th Annual DeGregorio Foundation Award for Cancers of the Esophagus and Stomach

The Foundation seeks to promote and facilitate collaborative research on the pathogenesis, early diagnosis, and treatment of upper gastrointestinal malignancies.  Sought is high quality, innovative, and transformative translational and bench research to improve the understanding of the biology of these diseases, identification of potential novel therapeutic targets, or in the development and evaluation of novel biomarkers for early diagnosis and treatment.  Pre-clinical research, basic mechanistic studies, genomic/epigenomic studies, as well as epidemiologic studies may also be supported.
Due Dates: Nov. 03 (OSR) Ι Nov. 07 (Sponsor)
Amount & Project Period: $250,000 (TOTAL) - 2 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
Link: Guidelines


NEW
November 10 All Faculty Ranks Non-Federal Melanoma

Harry J. Lloyd Charitable Trust
Melanoma Research Grants

Awards are made in three categories:  Career Development for promising young melanoma investigators, Basic Science for the purpose of gaining new biological insights in to melanoma development or progression, and Translational Research to fund clinically important melanoma research.  Special consideration will be given in three areas: 1) emerging novel concepts that constitute significant innovation, 2) new investigators in the field of melanoma, and 3) prevention and early detection.
Due Dates: Nov. 08 (OSR) Ι Nov. 10 (Sponsor)
Amount & Project Period: Career Development - $125,000/yr. - 3 years
Basic Science - $125,000/yr. - 3 years
Translational Science - $125,000/yr. - 3 years
Eligibility: All Faculty Ranks
Contact: Office of Sponsored Research (x6804)
Link: Application Guidelines


November 15 (LOI) All Faculty Ranks Non-Federal Immunotherapies

Technology Impact Grants

The grant aims to support development of highly innovative technologies that can ultimately be adopted by the research community at large and will enable researchers to develop the next generation cancer immunotherapies that can be effective and personalized for each patient. Technologies may facilitate understanding of the antigenic profile, cellular interplay, and mechanistic pathways within the tumor microenvironment that are essential for an effective anti-tumor response.
Due Dates: Nov. 15 (Letter of Intent)
Invited Applications:  Mar. 13 (OSR) Ι Mar. 15, 2018 (Sponsor)
Amount & Project Period: Up to $1,000,000 - 3  years
Eligibility: Tenure Track Assistant Professor or higher
Contact: Office of Sponsored Research (x6804)
Link: Overview | Impact Grants   


NEW
November 17 See Below Non-Federal Melanoma

Melanoma Research Alliance 2017-2018 Cycle

MRA is soliciting proposals that address the gap in translational science (i.e., turning scientific discoveries into tools and/or treatments for high-risk individuals and melanoma patients).
Due Dates: Nov. 15 (OSR) Ι Nov. 17 at 5p.m. (Sponsor)
Contact: Office of Sponsored Research (x6804)
To confirm eligibility contact Tasheema Prince at tprince@curemelanoma.org
Link: Overview  Ι  RFP
 

Young Investigator Award

Young Investigator Awards aim to attract early career scientists with novel ideas into the field of melanoma, thereby recruiting and supporting the next generation of melanoma research leaders and to help achieve innovative and creative, preclinical, translational, and/or early clinical research projects.
Amount & Project Period: $75,000/yr (Total cost) - 3 years  
Eligibility: Must be within four years of first independent, full time academic faculty appointment at the time of application at the level of Assistant Professor (or equivalent position).
 

Young Investigator Award for Women in Scientific Research

 MRA is proud to offer a Young Investigator Award with the goal of attracting and supporting early career female researchers who are conducting cutting-edge melanoma research. This award will support projects with the potential to lead to transformative advances in prevention, detection, diagnosis, staging or treatment of melanoma.
Amount & Project Period: $225,000 (Total cost) - 3 years  
Eligibility: Must be a woman.
Must be within four years of first independent, full time academic faculty appointment at the time of application at the level of Assistant Professor (or equivalent position).
R01 NCI

NEW
November 21 All Ranks Federal Nanotechnology

Innovative Research in Cancer Nanotechnology (IRCN)

IRCN awards are designed to enable multidisciplinary research and transformative discoveries in cancer biology and/or oncology through the use of nanotechnology. Proposals should address major barriers in cancer biology and/or oncology using nanotechnology and should emphasize fundamental understanding of nanomaterial and/or nanodevice interactions with biological systems. Scope includes research concerning the delivery of nanoparticles and/or nanodevices to desired and intended cancer targets in vivo and/or characterization of in vitro detection and diagnostic devices.
Due Dates: Nov. 17 (OSR) Ι Nov. 21 (Sponsor)
Amount & Project Period: Limited to $450,000/yr. (Direct Costs) - 5 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
FOA Link: PAR-17-240




NEW
December 01 All Ranks Non-Federal Clinical Oncology

Hope Foundation
SWOG Early Exploration and Development (SEED) Fund

 This award is a funding program from the Hope Foundation that encourages preliminary research that will potentially translate to future clinical trials or trial-associated projects (translational medicine studies) within SWOG and the National Clinical Trials Network (NCTN). This award may assist investigators with projects that support the following: pre-clinical data, secondary data analysis from clinical trials, pilot and feasibility studies (including early stage clinical trials), small, self-contained research projects, or development of research methodology/technology.
Due Dates: Nov. 29 (OSR) Ι Dec. 01 (5:00, pm ET) (Sponsor)
Amount & Project Period: $50,000 (Direct Costs) - 1-2 years  
Eligibility: Any SWOG member investigator eligible for NIH funding is encouraged to submit to this program
Contact: Office of Sponsored Research (x6804)
Link: SEED Fund Award  Ι  2017  RFA
Toolbox
Funding Opportunities

Funding Opportunity Calendar
OSR's Grant News
grants.gov
NCI Funding Opportunities
NIH Guide to Grants & Contracts

RaceTracks

 Federal Opportunities
Moffitt-Sponsored (Intramural) Opportunities
Opportunities Focused on Thoracic Oncology		 Grant Preparation

Proposal Submission Form
Grants.gov Instructions
PHS398 Instructions
NIH 2590 Instructions

News

 NIH Research Matters
The Cancer Letter
NIH News & Events
Federal Register
Science 360 News
 Other

PubMed
National Cancer Institute

Clinical Research

Who To Call in Clinical Research
Clinical Research FAQs
Data Safety Monitoring Plan
Liberty IRB
USF IRB
Questions?
MRISignals@moffitt.org